NCT01277081

Brief Summary

The aim of this study is to subjectively assess symptoms in subjects suffering from the common cold following a single dose of paracetamol hot drink compared to paracetamol tablet

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2010

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 12, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 14, 2011

Completed
4.1 years until next milestone

Results Posted

Study results publicly available

February 18, 2015

Completed
Last Updated

February 18, 2015

Status Verified

June 1, 2013

Enrollment Period

2 months

First QC Date

January 12, 2011

Results QC Date

June 27, 2013

Last Update Submit

February 2, 2015

Conditions

Keywords

ParacetamolCommon cold

Outcome Measures

Primary Outcomes (1)

  • Breathing Scores Post 15 Minutes

    A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

    Baseline to 15 minutes

Secondary Outcomes (5)

  • Breathing Score Post 60 Minutes

    Baseline to 60 minutes

  • Cold Symptoms Score Post 15 Minutes

    Baseline to 15 minutes

  • Cold Symptoms Score Post 60 Minutes

    Baseline to 60 minutes

  • Soothing Attribute Scores

    Baseline to 15 and 60 minutes

  • Overall Cold Symptoms Score

    Baseline to 15 and 60 minutes

Study Arms (2)

Paracetamol hot drink

ACTIVE COMPARATOR

Hot drink containing paracetamol

Drug: Paracetamol hot drink

Paracetamol tablets

ACTIVE COMPARATOR

Paracetamol tablets

Drug: Paracetamol tablets

Interventions

Hot drink containing paracetamol

Paracetamol hot drink

Paracetamol tablets

Paracetamol tablets

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptoms of the common cold of no more than 120 hours duration
  • Self-rating congestion of at least moderate severity
  • Suffering from at least four symptoms of common cold or flu

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Common Cold Centre

Cardiff, Wales, United Kingdom

Location

MeSH Terms

Conditions

Common Cold

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPicornaviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
GSK Response Center
Organization
GlaxoSmithKline

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2011

First Posted

January 14, 2011

Study Start

October 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

February 18, 2015

Results First Posted

February 18, 2015

Record last verified: 2013-06

Locations